Vehicle Safety
Recalls Search 320,000+ NHTSA safety recalls Complaints 2.1M+ consumer safety complaints TSBs 4.7M technical service bulletins VIN Lookup Decode any vehicle VIN instantly OBD Codes 12,000+ diagnostic trouble codes Fuel Economy EPA MPG data for all vehicles Safety Ratings 11,700+ NHTSA crash test ratings Investigations 5,300+ NHTSA defect investigations Statistics Recall trends & safety analysis
Consumer Safety
Product Safety 9,700+ CPSC product recalls Food Safety 28,600+ FDA food recalls Pet Safety 1.3M FDA animal adverse events Drug Safety 17,500+ FDA drug recalls Device Safety 38,400+ FDA device recalls Workplace Safety 102,900+ OSHA injury reports Brand History Cross-category recall lookup by company
Infrastructure
Bridge Safety 624,000 bridge inspections Aviation Safety 30,000+ NTSB aviation events Dam Safety 92,600 dam safety records Water Safety 433,000+ public water systems Railroad Safety 438,000+ rail crossings Pipeline Safety 8,800+ pipeline incidents State Safety Dashboards Safety grades for all 50 U.S. states ZIP Safety Report Check any 5-digit ZIP across 9 datasets
Public Health
Nursing Homes 14,700 CMS rated facilities Environmental 80,000+ hazardous sites & releases
Blog

Vehicle Safety

Vehicle Recalls320,000+ NHTSA safety recalls Browse VehiclesEvery make, model and year Complaints2.1M+ consumer safety complaints TSBs4.7M technical service bulletins VIN LookupDecode any vehicle VIN instantly OBD Codes12,000+ diagnostic trouble codes Fuel EconomyEPA MPG data for all vehicles Safety Ratings11,700+ NHTSA crash test ratings Investigations5,300+ NHTSA defect investigations StatisticsRecall trends & safety analysis Compare VehiclesTwo vehicles side by side

Consumer Safety

Product Safety9,700+ CPSC product recalls Food Safety28,600+ FDA food recalls Pet Safety1.3M FDA animal adverse events Drug Safety17,500+ FDA drug recalls Device Safety38,400+ FDA device recalls Workplace Safety102,900+ OSHA injury reports Brand HistoryRecall lookup by company

Infrastructure

Bridge Safety624,000 bridge inspections Aviation Safety30,000+ NTSB aviation events Dam Safety92,600 dam safety records Water Safety433,000+ public water systems Railroad Safety438,000+ rail crossings Pipeline Safety8,800+ pipeline incidents State DashboardsSafety grades for all 50 states ZIP ReportAny 5-digit ZIP across 9 datasets

Public Health

Nursing Homes14,700 CMS rated facilities Environmental80,000+ hazardous sites & releases BlogGuides, news & safety insights

Browse Drug Recalls

3,430 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 3,430 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 3,430 FDA drug recalls.

Clear
DateProductReasonClassFirm
Feb 19, 2019 Lovastatin Tablets USP, 40 mg, packaged in a) 100-count bottles (NDC 68001-31... CGMP Deviations: Finished product made with lovastatin drug substance that was out of specificati... Class III American Health Packaging
Feb 13, 2019 Lovastatin Tablets USP, 40 mg, packaged in a) 60-count (NDC 68180-469-07 and ... CGMP Deviations: Finished product made with lovastatin drug substance that was out of specificati... Class III Lupin Pharmaceuticals Inc.
Feb 4, 2019 0.9% Sodium Chloride Injection, USP 1000 mL flexible container, Rx only, Hos... CGMP Deviations Class II ICU Medical Inc
Jan 18, 2019 Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactu... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Prinston Pharmaceutical Inc
Jan 18, 2019 Irbesartan Tablets 300 mg 90 count Rx only Manufactured by: Zhejiang Huah... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Prinston Pharmaceutical Inc
Jan 18, 2019 Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactu... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Prinston Pharmaceutical Inc
Jan 18, 2019 Irbesartan and Hydrochlorothiazide Tablets, USP 150/12.5 mg Rx 30 Tablets Onl... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Prinston Pharmaceutical Inc
Jan 18, 2019 Irbesartan and HydrochlorothiazideTablets, USP 150/12.5 mg Rx Only 90 count ... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Prinston Pharmaceutical Inc
Jan 10, 2019 Losartan Potassium Tablets, USP. 50 mg. NDC# 0904-6390-61. Rx only. 100 count... CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in... Class II MAJOR PHARMACEUTICALS
Jan 9, 2019 Cephalexin for Oral Suspension USP 250mg/5 mL, Rx Only Manufactured for: Lu... CGMP Deviations; presence of extraneous material in the was observed in area that is between the... Class II Lupin Pharmaceuticals Inc.
Jan 7, 2019 Cephalexin for Oral Suspension USP, 250mg/5mL, 200 mL (when mixed), Rx only, ... CGMP Deviation; manufacturing batch record could not be located Class II Lupin Pharmaceuticals Inc.
Jan 2, 2019 Cefdinir for Oral Suspension USP, 125mg/5mL, packaged in a) 60mL (NDC 68180-7... CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to ... Class II Lupin Pharmaceuticals Inc.
Jan 2, 2019 Cefdinir for Oral Suspension USP, 250mg/5mL, packaged in a) 60mL (NDC 68180-7... CGMP Deviations: Product complaints received indicating reconstituted suspension was observed to ... Class II Lupin Pharmaceuticals Inc.
Dec 31, 2018 Valsartan tablets USP 320 mg, 90-count bottles, Rx Only, Manufactured for: Au... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 31, 2018 Amlodipine and Valsartan Tablets USP 10 mg/320 mg. 30-count bottles, Rx Only,... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 31, 2018 Valsartan and Hydrochlorothiazide tablets USP 160 mg/25 mg, 90-count bottle, ... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 31, 2018 Valsartan and Hydrochlorothiazide tablets USP 160mg/12.5 mg, 90-count bottle,... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 31, 2018 Amlodipine and Valsartan Tablets USP 5 mg/320 mg, 30-count bottles, Rx Only, ... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 31, 2018 Valsartan and Hydrochlorothiazide tablets USP 320 mg/25 mg, 90-count bottles,... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 31, 2018 Valsartan and Hydrochlorothiazide tablets USP 320mg/12.5 mg, 90-count bottle,... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 31, 2018 Amlodipine and Valsartan Tablets USP 5 mg/160 mg, 30-count bottles, Rx Only, ... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 31, 2018 Valsartan and Hydrochlorothiazide tablets USP 80 mg/12.5 mg, 90-count bottle,... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 31, 2018 Amlodipine and Valsartan Tablets USP 10 mg/160 mg, 30-count bottles, Rx Only,... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Aurobindo Pharma USA Inc.
Dec 20, 2018 LOSARTAN POTASSIUM TABLETS, USP, 25 mg, 90-count bottle (NDC: 13668-113-90), ... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Torrent Pharma Inc.
Dec 20, 2018 LOSARTAN POTASSIUM TABLETS, USP, 100 mg, a) 30-count (NDC: 13668-115-30), b) ... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Torrent Pharma Inc.
Dec 20, 2018 LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS, USP, 100 mg/12.5 mg, a) ... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Torrent Pharma Inc.
Dec 20, 2018 LOSARTAN POTASSIUM and HYDROCHLOROTHIAZIDE TABLETS, USP 50 mg/12.5 mg, a) 90... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Torrent Pharma Inc.
Dec 20, 2018 LOSARTAN POTASSIUM TABLETS, USP, 50 mg, a) 30-count bottle (NDC: 13668-409-30... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained ... Class II Torrent Pharma Inc.
Dec 19, 2018 Oxygen, Refrigerated Liquid USP, Rx only, cylinder, a) Roberts Home Medical, ... CGMP Deviations Class II Roberts Home Medical LLC
Dec 18, 2018 CIDOFOVIR DIHYDRATE, (Non-Sterile, For Manufacturing Use), 10g, Rx only, ALP ... CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert. Class II LGM Pharma LLC
Nov 27, 2018 Amlodipine and Valsartan Tablets 5 mg/160 mg, (a) 30-count bottles (NDC 0093-... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... Class II Teva Pharmaceuticals USA
Nov 27, 2018 Amlodipine and Valsartan Tablets 5 mg/320 mg, (a) 30-count bottles (NDC 0093-... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... Class II Teva Pharmaceuticals USA
Nov 27, 2018 Amlodipine and Valsartan Tablets 10 mg/320 mg (a) 30-count bottles (NDC 0093... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... Class II Teva Pharmaceuticals USA
Nov 27, 2018 Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/320 mg/25 mg, (... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... Class II Teva Pharmaceuticals USA
Nov 27, 2018 Amlodipine and Valsartan Tablets 10 mg/160 mg, (a) 30-count bottles (NDC 0093... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... Class II Teva Pharmaceuticals USA
Nov 27, 2018 Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/160 mg/12.5 mg, ... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... Class II Teva Pharmaceuticals USA
Nov 27, 2018 Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 10 mg/160 mg/25 mg, (... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... Class II Teva Pharmaceuticals USA
Nov 27, 2018 Amlodipine, Valsartan, and Hydrochlorothiazide Tablets 5 mg/160 mg/12.5 mg, ... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodimethylamine... Class II Teva Pharmaceuticals USA
Nov 20, 2018 Amlodipine and Valsartan Tablets, USP,10 mg/160 mg, 30-count bottle, Rx Only,... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... Class II Mylan Pharmaceuticals Inc.
Nov 20, 2018 Amlodipine and Valsartan Tablets, USP, 10 mg/320 mg, 30-count bottle, Rx Only... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... Class II Mylan Pharmaceuticals Inc.
Nov 20, 2018 Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg, 30-count bottle, Rx Only,... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... Class II Mylan Pharmaceuticals Inc.
Nov 20, 2018 Valsartan Tablets, USP, 320 mg, 90-count bottle, Rx Only, Made in India, Manu... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... Class II Mylan Pharmaceuticals Inc.
Nov 20, 2018 Valsartan Tablets, USP, 40 mg, 30-count bottle, Rx Only, Made in India, Manuf... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... Class II Mylan Pharmaceuticals Inc.
Nov 20, 2018 Valsartan Tablets, USP, 160 mg, 90-count bottle, Rx Only, Made in India, Manu... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... Class II Mylan Pharmaceuticals Inc.
Nov 20, 2018 Valsartan and Hydrochlorothiazide Tablets, USP, 320 mg/25 mg, (a) 500-count b... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... Class II Mylan Pharmaceuticals Inc.
Nov 20, 2018 Valsartan Tablets, USP, 80 mg, 90-count bottles, Rx Only, Made in India, Manu... CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained i... Class II Mylan Pharmaceuticals Inc.
Nov 16, 2018 SHEER DesenZ Desensitizing Treatment, Rx Only, Potassium Nitrate 12mg per fil... cGMP violations noted during the firm's most recent inspection. Class II CAO Group, Inc.
Nov 16, 2018 fas.TRACT Coagulative Hemostatic Gel, 10% Ferric Sulfate Kit, Rx Only, (3) 3c... cGMP violations noted during the firm's most recent inspection. Class II CAO Group, Inc.
Nov 16, 2018 FastStat Topical Hemostat Introductory Kit, 10% Ferric Sulfate 10%, Rx Only, ... cGMP violations noted during the firm's most recent inspection. Class II CAO Group, Inc.
Nov 16, 2018 BeeGentle Honey Flavored Topical Anesthetic, Active ingredient Benzocaine 20%... cGMP violations noted during the firm's most recent inspection. Class II CAO Group, Inc.

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.